Skip to main content
TipRanks
Go Ultimate75% OFF

Santen Pharmaceutical Co (SNPHY) Q1 2022 Earnings Report

6 Followers

SNPHY Q1 2022 EPS Results

Actual EPS
$0.13
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
$0.17

SNPHY Q1 2022 Revenue Results

Actual Revenue
$505.69M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-14.87%

Earnings Announcement Details

Quarter
Q1 2022
Date
08/04/2022
Time
TBA
Conference Call
Thursday, August 4, 2022
SNPHY Upcoming Earnings

Santen Pharmaceutical Co's next earnings date is estimated for February 9, 2027, based on past reporting schedules.

Q1 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

SNPHY Earnings History

SNPHY earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 09, 20272026 (Q3)―-0.16――
Nov 05, 20262026 (Q2)―0.160.17-3.01% (-0.01)
Aug 06, 20262026 (Q1)―0.140.1216.67% (+0.02)
May 12, 20262025 (Q4)―0.310.1782.25% (+0.14)
Feb 05, 20262025 (Q3)―0.160.17-4.82% (-0.01)
Nov 06, 20252025 (Q2)―0.170.166.41% (+0.01)
Aug 07, 20252025 (Q1)―0.120.19-36.84% (-0.07)
May 13, 20252024 (Q4)―0.17016800.00% (+0.17)
Feb 06, 20252024 (Q3)―0.170.1418.57% (+0.03)
Nov 07, 20242024 (Q2)―0.160.17-8.24% (-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed